Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lenalidomide × CNS × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Completed 6 Terminated 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 32 Plasma cell 19 Other hematologic neoplasm 7 Myeloid 3 Gastrointestinal 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 56 Radiotherapy 45 Carboplatin 21 Radiosurgery 17 Cisplatin 16 Etoposide 15 Bevacizumab 15 Cyclophosphamide 14 Vincristine 13 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 12 Lomustine 9 Chemotherapy, Adjuvant 9 Melphalan 8 Erlotinib Hydrochloride 8 apatinib 7 anlotinib 7 Radiation 7 Pemetrexed 7 3-Iodobenzylguanidine 7 Filgrastim 6 Carmustine 6 Blood Specimen Collection 6 aumolertinib 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Neoadjuvant Therapy 5 Irinotecan 5 Drug Therapy 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡